Literature DB >> 43383

Apparent dose-dependent absorption of chlorothiazide in dogs.

D E Resetarits, T R Bates.   

Abstract

The purpose of this study was to determine the effect of oral dose on the absorption of chlorothiazide in the dog. Chlorothiazide was quantitatively excreted in the urine after administration of 50-mg and 250-mg intravenous doses. In contrast, the urinary recovery of chlorothiazide after oral administration showed appreciable interanimal variation and decreased from 70.4% to 26.7% on the average as the oral dose was increased from 125 mg to 750 mg. Oral administration of a single 15-mg dose of propantheline bromide (a potent inhibitor of gastric emptying and intestinal motility) at--1 hr increased the absorption of a 250 mg oral dose of chlorothiazide in three out of four dogs. These results suggest that chlorothiazide absorption is dose dependent and apparently site specific.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43383     DOI: 10.1007/bf01062388

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  11 in total

1.  Studies with chlorothiazide tagged with radioactive carbon (C14) in human beings.

Authors:  H R BRETTELL; J K AIKAWA; G S GORDON
Journal:  Arch Intern Med       Date:  1960-07

2.  Intestinal pH as a factor in selection of animal models for bioavailability testing.

Authors:  W G Crouthamel; C R Abolin; J Hsieh; J K Lim
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

3.  Errors in chlorothiazide bioavailability estimates based on a Bratton--Marshall colorimetric method for chlorothiazide in urine.

Authors:  D E Resetarits; T R Bates
Journal:  J Pharm Sci       Date:  1979-01       Impact factor: 3.534

4.  Effect of colestipol on gastrointestinal absorption of chlorothiazide in man.

Authors:  R E Kauffman; D L Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

5.  Pharmacokinetics of hydrochlorothiazide in man.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

6.  Bioavailability of two hydrochlorothiazide preparations.

Authors:  B Beermann; M Groschinsky-Grind; B Lindstrom
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

7.  Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

8.  Absorption, metabolism, and excretion of hydrochlorothiazide.

Authors:  B Beermann; M Groschinsky-Grind; A Rosén
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

9.  Enhancement of the gastrointestinal absorption of hydrochlorothiazide by propantheline.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

10.  The physiological disposition of chlorothiazide (diuril) in the dog.

Authors:  J E BAER; H L LEIDY; A V BROOKS; K H BEYER
Journal:  J Pharmacol Exp Ther       Date:  1959-04       Impact factor: 4.030

View more
  7 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Relative bioavailability of chlorothiazide from mucoadhesive compacts in pigs.

Authors:  Karunakar Neelam; Ravichandran Mahalingam; Raj Birudaraj; Tom Alfredson; Pratap Anne; Xiaoling Li; Bhaskara R Jasti
Journal:  AAPS PharmSciTech       Date:  2009-11-10       Impact factor: 3.246

Review 3.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

4.  Michaelis-Menten absorption kinetics in drugs: - examples and implications.

Authors:  J H Wood; K M Thakker
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.

Authors:  W L Chiou; H Y Jeong; S M Chung; T C Wu
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

6.  Comparison of canine and human gastrointestinal physiology.

Authors:  J B Dressman
Journal:  Pharm Res       Date:  1986-06       Impact factor: 4.200

Review 7.  Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Authors:  Nadia O Bamfo; Chelsea Hosey-Cojocari; Leslie Z Benet; Connie M Remsberg
Journal:  Pharm Res       Date:  2021-07-12       Impact factor: 4.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.